Login / Signup

ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.

Daryl K A ChiaRaghav SundarGuowei KimJia Jun AngJeffrey H Y LumMin En NgaGiap Hean GohJe Ee SeetCheng Ean CheeHon Lyn TanJingshan HoNatalie Y L NgoiMatilda X W LeeVaishnavi MuthuGloria H J ChanAngela S L PangYvonne L E AngJoan R E ChooJoline S J LimJun Liang TehAung LwinYuen SoonAsim ShabbirJimmy Bok-Yan SoWei Peng Yong
Published in: Annals of surgical oncology (2022)
Keyphrases
  • phase ii study
  • locally advanced
  • open label
  • placebo controlled
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • randomized controlled trial
  • adipose tissue
  • drug induced
  • insulin resistance